Infection control in the ICU environment
著者
書誌事項
Infection control in the ICU environment
(Perspectives on critical care infectious diseases, 5)
Kluwer Academic, c2002
- : hardback
大学図書館所蔵 全3件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and index
HTTP:URL=http://www.loc.gov/catdir/enhancements/fy0819/2001038474-d.html Information=Publisher description
HTTP:URL=http://www.loc.gov/catdir/enhancements/fy0819/2001038474-t.html Information=Table of contents only
内容説明・目次
内容説明
Infection Control in the ICU Environment provides the details of the most common infection control problems facing intensive care units. Authors include noted scientists, intensivists and epidemiologists from the United States and Europe as well as infection control experts from the Centers for Disease Control and Prevention.
Acinetobacter, methicillin resistant staphylococcus aureus and vancomycin resistant enterococci are examined in detail. This volume also includes cutting edge information regarding the potential for prophylactic and pre-emptive therapy of fungal infections in intensive care units.
Innovations in vascular catheter care and prevention of bloodstream infections are discussed in this volume as well as the newest information in mathematical modeling to understand the epidemiology and control of infections in intensive care units.
目次
- Contributors. Introduction
- J. Rello. Preface. 1. Scope and Magnitude of Nosocomial ICU Infections. U.S. Perspective
- J. Alonso-Echanove, R.P. Gaynes. 2. Scope and Magnitude of Nosocomial ICU Infections. European Perspective
- M.M.S. Ibelings, H.A. Bruining. 3. Vancomycin-Resistant Enterococci: A Threat for the ICU? U.S. Perspective
- M.K. Hayden. 4. Vancomycin-Resistant Enterococci in Europe: A Changing Epidemiology? European Perspective
- M.J.M. Bonten. 5. Methicillin-Resistant Staphylococcus Aureus: Is Control Necessary? U.S. Perspective
- J.M. Boyce. 6. Acinetobacter: Epidemiology and Control. U.S. Perspective
- J.J. Rahal, C. Urban. 7. Acinetobacter: Epidemiology and Control. European Perspective
- J. Ariza, X. Corbella. 8. Fungal Infections: The Role of Prophylactic and Empiric Antifungal Therapy in ICU Patients. U.S. Perspective
- P.O. Gubbins. 9. Fungal Infections: The Role of Prophylaxis and Empiric Therapy in ICU Patients. European Perspective
- J.F.G.M. Meis, P.E. Verweij. 10. Newer Approaches to Preventing Vascular Catheter-Related Sepsis. U.S. Perspective
- R.O. Darouiche. 11. Newer Approaches to Preventing Intravascular Device-Related Bloodstream Infections. European Perspective
- J.A.J.W. Kluytmans. 12. Is Prevention of Ventilator-Associated Pneumonia Cost Effective? North American Perspective
- M.H. Kollef. 13. Ventilator-Associated Pneumonia: Is Prevention Cost Effective? European Perspective
- R. Ferrer, et al. 14. Cross-Colonization in Intensive Care Units: Fact or Fiction? U.S. Perspective: M. Samore.15. Cross-Colonization: Fact or Fiction? European Perspective
- M.S. Garcia. 16. Conventional Infection Control Measures: Value or Ritual? U.S. Perspective
- J.P. Flaherty, et al. 17. Conventional Infection Control Measures: Value or Ritual? European Perspective
- C.A.M. Schurink, M.J.M. Bonten. 18. Modeling of Antibiotic Resistance in the ICU. U.S. Perspective
- M. Lipsitch, C.T. Bergstrom. 19. Mathematical Models in the ICU: Dynamics, Infection Control and Antibiotic Resistance. European Perspective
- D.J. Austin. Index.
「Nielsen BookData」 より